Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer (NCT06627075) | Clinical Trial Compass
RecruitingNot Applicable
Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer
France40 participantsStarted 2024-12-12
Plain-language summary
The goal of this clinical trial is to test the use of surface repositioning alone, without a restraint mask, during radiotherapy sessions for patients with head and neck cancer.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients over 18 years of age
* Patients undergoing palliative or curative treatment for oro-rhino-laryngeal cancer
* Patients with an indication for radiotherapy treatment, with or without complementary treatment (chemotherapy, immunotherapy), with a number of sessions between 10 and 35
* Patients who have dated and signed an informed consent form
Exclusion Criteria:
* Patients with uncontrollable movements
* Patients under psychiatric care
* Patients who do not understand or read French
* Patients participating in an interventional study testing another medical intervention
* Patients under guardianship, curatorship, safeguard of justice or deprived of liberty
* Pregnant or breast-feeding women
* Patients without social security coverage
What they're measuring
1
Measurement patient displacement during surface-guided radiotherapy sessions
Timeframe: Through study completion, an average of 1 year